<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Erwin Mulyawan</style></author><author><style face="normal" font="default" size="100%">Muhammad Ramli Ahmad</style></author><author><style face="normal" font="default" size="100%">Andi Asadul Islam</style></author><author><style face="normal" font="default" size="100%">Muh Nasrum Massi</style></author><author><style face="normal" font="default" size="100%">Mochammad Hatta</style></author><author><style face="normal" font="default" size="100%">Syafri Kamsul Arif</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Analysis of GABRB3 Protein Level After Administration of Valerian Extract (Valeriana officinalis) in BALB/c mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">BALB/c mice</style></keyword><keyword><style  face="normal" font="default" size="100%">Diazepam</style></keyword><keyword><style  face="normal" font="default" size="100%">GABRB3 protein</style></keyword><keyword><style  face="normal" font="default" size="100%">Valerian extract</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">821-827</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Valeriana officinalis is most commonly used as traditional medicine. Valerenic acid is the primary component of Valerian officinalis which inhibits the catabolism of enzyme induced breakdown of gamma amino butyric acid (GABA) in the brain, resulting in sedation. The aim of this study is to determine the level of GABRB3 protein, as part of major inhibitory neurotransmitter in the brain, after administration of Valerian extracts in BALB/c mice. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; This is an experimental study using animal model with post test-only controlled group design. Twenty healthy adult male BALB/c mice were randomly divided into four groups, negative control group (Aquadest), positive control group (Diazepam 0.025 mg/10 g), first treatment group (Valerian extract 2.5 mg/10 g) and second treatment group (Valerian extract 5 mg/10 g). The drugs were administered via gastric gavage for seven consecutive days. The blood was drawn from each mice on the first day (before treatment) and on the seventh day of experiment (2 hours after treatment). The blood sample was examined by enzyme-linked immunosorbent assay (ELISA) to determine the GABRB3 protein level. &lt;strong&gt;Results: &lt;/strong&gt;GABRB3 protein level in BALB/c mice after administration of Valerian extract was increased significantly in both treatment group (&lt;em&gt;p &lt;/em&gt;&amp;lt;0.0001). The highest increment in protein levels was found in the first treatment group with an increase of 2.988 μmol/L, compared with the second treatment group with an increase of 2.146 μmol/L. &lt;strong&gt;Conclusion: &lt;/strong&gt;GABRB3 protein level in BALB/c mice were increased after administration of Valerian extract. Administration of higher dose does not yield in higher GABRB3 protein level nor sedative effect.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">821</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Erwin Mulyawan&lt;sup&gt;1,&lt;/sup&gt;*, Muhammad Ramli Ahmad&lt;sup&gt;2&lt;/sup&gt;, Andi Asadul Islam&lt;sup&gt;3&lt;/sup&gt;, Muh. Nasrum Massi&lt;sup&gt;4&lt;/sup&gt;, Mochammad Hatta&lt;sup&gt;4&lt;/sup&gt;, Syafri Kamsul Arif&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Anesthesiology, Faculty of Medicine, Pelita Harapan University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Anesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Hasanuddin University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Neurosurgery, Faculty of Medicine, Hasanuddin University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Molecular Biology and Immunology, Faculty of Medicine, Hasanuddin University, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abdulrahman Alsayari</style></author><author><style face="normal" font="default" size="100%">Mohammed Ghazwani</style></author><author><style face="normal" font="default" size="100%">Dalia Almaghaslah</style></author><author><style face="normal" font="default" size="100%">Yahya Alhamhoom</style></author><author><style face="normal" font="default" size="100%">Maha Saad</style></author><author><style face="normal" font="default" size="100%">Rawan Ahmed</style></author><author><style face="normal" font="default" size="100%">Wafa Saeed</style></author><author><style face="normal" font="default" size="100%">Wijden Ali</style></author><author><style face="normal" font="default" size="100%">Sadia Batool</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Bombax ceiba: A Potential Anti-Anxiety Drug</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-anxiety</style></keyword><keyword><style  face="normal" font="default" size="100%">Bombax ceiba leaves</style></keyword><keyword><style  face="normal" font="default" size="100%">Diazepam</style></keyword><keyword><style  face="normal" font="default" size="100%">Elevated Plus Maze</style></keyword><keyword><style  face="normal" font="default" size="100%">Ethanol</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/656</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">712-714</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; &lt;em&gt;Bombax ceiba &lt;/em&gt;is a famous plant used extensively in traditional medicine for various diseases. However, data pertaining to its effects at CNS level is limited. &lt;strong&gt;Objective:&lt;/strong&gt; To analyze the anti-anxiety potential of ethanolic extracts of &lt;em&gt;Bombax ceiba&lt;/em&gt; leaves on rats using the elevated plus maze protocol. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Five groups containing six rats each were treated with respective drugs.Control rats were treated with 0.5ml of 10% ethanol i.p. (negative control). Single treatments of diazepam (2mg/kg i.p) were used as a positive control and varied levels of ethanolic extracts of &lt;em&gt;Bombax ceiba&lt;/em&gt; leaves (150 mg/kg, 250 mg/kg, 400 mg/kg, i.p.) were applied to other groups. The index of anxiety was measured by observing the entry and time duration in the open arm of the EPM. &lt;strong&gt;Results:&lt;/strong&gt; Extract at 400 mg/kg significantly increased the time duration and number of entries into the open arm which was statistically significant (p value &amp;lt;0.05) when compared to the control group (ethanol). Diazepam showed the most significant results when compared to other groups (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.0005). Extracts at 150 mg/kg and 250 mg/kg demonstrated negligible results that were statistically insignificant. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results indicate the anti-anxiety potential of &lt;em&gt;Bombax ceiba&lt;/em&gt; leaves at higher concentration. Further studies are required to analyze the implicated phytochemicals and the mechanism at cellular level.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">712</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Abdulrahman Alsayari, Mohammed Ghazwani, Dalia Almaghaslah, Yahya Alhamhoom, Maha Saad, Rawan Ahmed, Wafa Saeed, Wijden Ali, Sadia Batool&lt;sup&gt;*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;College of Pharmacy, King Khalid University, Abha, KINGDOM OF SAUDIA ARABIA.&lt;/p&gt;</style></auth-address></record></records></xml>